Suppr超能文献

一种口服活性血管紧张素转换酶抑制剂对人类高血压的长期治疗。

Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor.

作者信息

Brunner H R, Gavras H, Turini G A, Waeber B, Cappuis P, McKinstry D N

出版信息

Clin Sci Mol Med Suppl. 1978 Dec;4:293s-295s. doi: 10.1042/cs055293s.

Abstract
  1. Captopril or SQ 14 225, administered orally twice a day, reduced the blood pressure of hypertensive patients whatever their clinical diagnosis and even when their plasma renin activity was 'normal' or low. 2. Long-term administration of captopril, either alone or together with diuretics, provides a powerful new tool with which to treat ambulatory hypertensive patients. 3. The renin system may play an important role in maintaining blood pressure in a majority of hypertensive patients.
摘要
  1. 卡托普利或SQ 14 225,每日口服两次,无论高血压患者的临床诊断如何,即使其血浆肾素活性“正常”或较低,均可降低血压。2. 长期单独使用卡托普利或与利尿剂联合使用,为治疗门诊高血压患者提供了一种强有力的新工具。3. 肾素系统可能在大多数高血压患者的血压维持中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验